RAPP
$29.37+2.69%
Rapport Therapeutics Inc.Stock · HealthcareRussell 2000 · 0.04% of IWMNasdaq Composite · 0.006% of ONEQUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV
Rapport Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 20, 2026
Rapport Therapeutics Inc. total returns by year (2025–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $30.34 | $29.37 | 0.0% | -3.2% | |
| 2025 | $17.74 | $30.34 | 0.0% | +71.0% |
- Annualized
- +10.6%
- 2025–2026
- Average year
- +71.0%
- 1 full years
- Best year
- +71.0%
- 2025
- Worst year
- +71.0%
- 2025
- Positive years
- 1/1
- 100% up
Annualized (CAGR)
+10.6%
2025–2026
Average year
+71.0%
1 full years
Best year
+71.0%
2025
Worst year
+71.0%
2025
Positive years
1/1
100% up
Total return by period#
Annual
-60%-40%-20%0%20%40%60%
2025+71%'25
2026-3.2%'26
Methodology#
Total returns, dividends reinvested, measured on RAPP. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Rapport Therapeutics Inc.'s average annual return?
- Since 2025, Rapport Therapeutics Inc. (RAPP) has returned about 10.6% a year (the compound annual growth rate) and an average calendar-year return of 71.0%.
- What were Rapport Therapeutics Inc.'s best and worst years?
- Over 2025–2026, the best year was 2025 (+71.0%) and the worst was 2025 (+71.0%).
- How often is Rapport Therapeutics Inc. up in a year?
- 1 of the 1 full years since 2025 were positive — about 100% of the time.
More on Rapport Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100